Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma

  1. Powles, T.
  2. Assaf, Z.J.
  3. Degaonkar, V.
  4. Grivas, P.
  5. Hussain, M.
  6. Oudard, S.
  7. Gschwend, J.E.
  8. Albers, P.
  9. Castellano, D.
  10. Nishiyama, H.
  11. Daneshmand, S.
  12. Sharma, S.
  13. Sethi, H.
  14. Aleshin, A.
  15. Shi, Y.
  16. Davarpanah, N.
  17. Carter, C.
  18. Bellmunt, J.
  19. Mariathasan, S.
Aldizkaria:
European Urology

ISSN: 1873-7560 0302-2838

Argitalpen urtea: 2023

Mota: Artikulua

DOI: 10.1016/J.EURURO.2023.06.007 GOOGLE SCHOLAR